Youlan Chen

Youlan Chen


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 June 2025 in Diabetology & Metabolic Syndrome
Verified
Journal Article
Open access
PDF file
WCWen Chen
Wen Chen
DCDebin Chen
Debin Chen
YZYizhou Zhuang
Yizhou Zhuang
LXLiying Xu
Liying Xu
YWYaojie Wang
Yaojie Wang
JZJianhui Zhao
Jianhui Zhao
Metabolic syndrome (MetS) has a high prevalence in the United States (US); however, limited research comprehensively evaluates the relationship between muscle quality index (MQI) and MetS. This study aims to investigate the association between MQI and MetS. Adults aged 20–60 years from the 2011–2014 National Health and Nutrition Examination Survey were included. Handgrip strength (HGS) was measured using a dynamometer, and appendicular skeletal muscle mass (ASM) was assessed via dual-energy X-ray absorptiometry. MQI_total was calculated as the sum of HGS from both hands divided by ASM. Weighted multivariable logistic regression models and restricted cubic splines (RCS) were used to explore the association between MQI_total and MetS, and subgroup, interaction, and sensitivity analyses were conducted. A total of 4,503 US residents were included in the study, with 1,165 diagnosed with MetS, yielding a prevalence of 25.9% (1,165/4,503). The weighted multivariable logistic regression model indicated that after adjusting for multiple covariates, MQI was negatively associated with the risk of MetS (odds ratio [OR] = 0.49, 95%CI: 0.32–0.73). Among the different components of MetS, MQI was negatively associated with elevated waist circumference (OR = 0.19, 95%CI: 0.12–0.28), elevated high-density lipoprotein cholesterol (OR = 0.66, 95%CI: 0.51–0.85), and elevated serum triglycerides (OR = 0.66, 95%CI: 0.51–0.85). RCS revealed a negative linear relationship between MQI and MetS (P < 0.001, Pnon−linear = 0.98). Low MQI is associated with an increased risk of MetS, exhibiting a linear relationship. These findings suggest that improving muscle quality may be an effective strategy for the prevention of MetS.

29 November 2024 in Cancer Epidemiology
Verified
Journal Article
Closed access
AWAhua Wu
Ahua Wu
ZGZhinan Guo
Zhinan Guo
YLYilan Lin
Yilan Lin
JCJiahuang Chi
Jiahuang Chi
YLYanqi Lan
Yanqi Lan
YCYoulan Chen
Youlan Chen

1 December 2025 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
DTDan Tang
Dan Tang
ZGZhinan Guo
Zhinan Guo
JCJuanjuan Chen
Juanjuan Chen
YCYoulan Chen
Youlan Chen
YZYidun Zhang
Yidun Zhang
Smoking is a leading risk factor for numerous adverse health outcomes. However, in the context of a dramatically increasing aging population, evidence on h

5 April 2024 in Digestive and Liver Disease
Verified
Journal Article
Closed access
YLYanqi Lan
Yanqi Lan
ZGZhinan Guo
Zhinan Guo
JDJunsheng Dai
Junsheng Dai
KCKailin Chen
Kailin Chen
YCYoulan Chen
Youlan Chen

4 August 2025 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
DCDebin Chen
Debin Chen
YLYining Li
Yining Li
YZYizhou Zhuang
Yizhou Zhuang
YWYaojie Wang
Yaojie Wang
YYYongju Ye
Yongju Ye
JZJianhui Zhao
Jianhui Zhao

6 January 2025 in Renal Failure
Verified
Journal Article
Open access
DCDebin Chen
Debin Chen
YYYongju Ye
Yongju Ye
YLYining Li
Yining Li
EXErxu Xue
Erxu Xue
QZQiJun Zhang
QiJun Zhang
JZJianhui Zhao
Jianhui Zhao
Chronic kidney disease (CKD) is a prevalent chronic, non-communicable disease. The long-term health effects of dietary live microbes, primarily probiotics, on CKD patients remain insufficiently understood. This study aims to investigate the association between dietary intake of live microbes and long-term health outcomes among individuals with CKD. Utilizing the National Health and Nutrition Examination Survey (NHANES) database, Cox regression analysis assessed the association between medium and high categories dietary live microbe intake and health outcomes (all-cause, cardiovascular disease [CVD], and cancer-related mortality) in CKD patients. A total of 3,646 CKD patients were enrolled. During the follow-up period, 1,593 all-cause mortality events were recorded, including 478 CVD deaths and 268 cancer deaths. In the fully adjusted model, compared to CKD patients in the lowest quartile (quartile 1) of live microbes intake, those in quartiles 3 and 4 exhibited a 20% and 26% reduced risk of all-cause mortality, with hazard ratios (HR) of 0.80 (95% confidence interval, CI: 0.69, 0.94) and 0.74 (95% CI: 0.62, 0.90), respectively. Additionally, compared to those with low live microbe intake (quartile 1), higher live microbe intake in quartile 4 was associated with a 37% reduction in the risk of CVD mortality for CKD patients, with an HR of 0.63 (95% CI: 0.45, 0.88). Consistent results were observed in subgroup and sensitivity analyses. A significant negative association was observed between live microbe intake and the risk of all-cause mortality as well as CVD mortality in the CKD population, with a p-value for trend < 0.05. Our study indicated that high dietary live microbe intake could mitigate the risk of all-cause and CVD mortality in CKD patients. These findings support the inclusion of live microbes in dietary recommendations, highlighting their significant roles in CKD.